Outcome of patients aged over 75 years who received a pacemaker to treat sinus node dysfunction

Archives of Cardiovascular Diseases

Volumn 104, Issue 2, 2011, Pages 89-96

  Steinbach, Mathieu ^a   Douchet, Marie Pierre ^b   Bakouboula, Babe ^b   Bronner, François ^b   Chauvin, Michel ^b  

^a Centre Hospitalier de Haguenau   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Dual chamber pacemaker; Elderly patients; Sinus node dysfunction

Indexed keywords

AGED; ARTICLE; DEATH; FATALITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE PACING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PROGNOSIS; RETROSPECTIVE STUDY; SINUS NODE DYSFUNCTION; SUDDEN DEATH; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; EQUIPMENT DESIGN; FEMALE; HEART FAILURE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SICK SINUS SYNDROME; STROKE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952898998     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2010.11.006     Document Type: Article

References (19)

1. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854-62.
2. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000;342:1385-91. (Pubitemid 30262395)
3. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23. (Pubitemid 36014128)
4. Sweeney MO, Bank AJ, Nsah E, et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-8. (Pubitemid 47367079)
5. Schmidt B, Brunner M, Olschewski M, et al. Pacemaker therapy in very elderly patients: long-term survival and prognostic parameters. Am Heart J 2003;146:908-13. (Pubitemid 37378583)
6. Brutel C, Omalek L. Projections démographiques pour la France, ses régions et ses départements (horizon 2030/2050). Insee Résultats Société 2003;16:1-40.
7. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
8. Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002;25: 260-4. (Pubitemid 34214606)
9. Andersen H, Nielsen J. Single-lead ventricular pacing is no longer an option for sick sinus syndrome. J Am Coll Cardiol 2004;43:2072-4. (Pubitemid 38686804)
10. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-6. (Pubitemid 127445094)
11. Kristensen L, Nielsen JC, Pedersen AK, et al. AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker. Pacing Clin Electrophysiol 2001;24:358-65. (Pubitemid 32281512)
12. Nielsen JC, Kristensen L, Andersen HR, et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 2003;42:614-23.
13. Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European society of cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95. (Pubitemid 47428944)
14. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271: 840-4.
15. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52. (Pubitemid 28446646)
16. Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an active W substudy. J Am Coll Cardiol 2007;50: 2156-61. (Pubitemid 350123679)
17. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107: 2932-7. (Pubitemid 36736635)
18. Sweeney MO, Hellkamp AS. Heart failure during cardiac pacing. Circulation 2006;113:2082-8.
19. Flaker G, Greenspon A, Tardiff B, et al. Death in patients with permanent pacemakers for sick sinus syndrome. Am Heart J 2003;146:887-93. (Pubitemid 37378580)